0 Commentaires
0 Parts
635 Vue
0 Aperçu
Rechercher
Découvrez de nouvelles personnes, créer de nouvelles connexions et faire de nouveaux amis
-
Fil d’actualités
- EXPLORER
-
Pages
-
Groupes
-
Evènements
-
Blogs
-
Offres
-
Emplois
-
Courses
-
Connectez-vous pour aimer, partager et commenter!
-
Atopic Dermatitis Market Outlook with Advancements in Targeted ImmunotherapiesPolaris Market Research has introduced the latest market research report titled Atopic Dermatitis Market Size, Share, Trends, Industry Analysis Report: By Drug Class (Biologics, Calcineurin Inhibitors, Corticosteroids, PDE4 Inhibitors, and Others), Route of Administration, Therapy, and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) – Market...0 Commentaires 0 Parts 439 Vue 0 Aperçu
-
Atopic Dermatitis Market Size, Share, Dermatology Treatment Trends and Forecast Report 2026–2033" According to the latest report published by Data Bridge Market Research, the Atopic Dermatitis Market The atopic dermatitis market is expected to gain growth at a potential rate of 8.70% in the forecast period of 2021 to 2028 and is expected to reach a value of USD 8.68 billion by 2028. The strong product pipeline for atopic dermatitis is the factors for the market growth. The...0 Commentaires 0 Parts 58 Vue 0 Aperçu
-
Atopic Dermatitis Market Size, Share, Dermatology Treatment Trends and Forecast Report 2026–2033" According to the latest report published by Data Bridge Market Research, the Atopic Dermatitis Market The atopic dermatitis market is expected to gain growth at a potential rate of 8.70% in the forecast period of 2021 to 2028 and is expected to reach a value of USD 8.68 billion by 2028. The supreme Atopic Dermatitis Market research report has been built by skilful and...0 Commentaires 0 Parts 56 Vue 0 Aperçu
-
Atopic Dermatitis Market: How Is the AD Pipeline Beyond Approved Therapies Advancing?Atopic dermatitis pipeline therapies — the next wave of investigational biologics, small molecules, and emerging approaches in Phase II and III development — represent the future commercial AD market evolution that will expand treatment options beyond the currently approved agents, with the Atopic Dermatitis Market reflecting pipeline development as a market future dimension....0 Commentaires 0 Parts 247 Vue 0 Aperçu
-
Atopic Dermatitis Treatment Market Size, Share and Clinical Trends 2032Atopic Dermatitis Treatment Market Overview The global atopic dermatitis treatment market continues to grow rapidly as awareness of chronic skin diseases and demand for long-term dermatological care increases. In 2024, the market was valued at nearly USD 17.05 Billion , and forecasts indicate it will exceed USD 32.04 Billion by 2032, with a CAGR of around 8.20 % during...0 Commentaires 0 Parts 372 Vue 0 Aperçu
-
Canine Atopic Dermatitis Market: Is 2026 "AI Skin Mapping" the End of Mystery Rashes?In 2026, the canine atopic dermatitis market is witnessing the integration of "Cloud-Based Diagnostic AI" that can identify specific allergens from a simple smartphone photo. In 2026, the market is identifying "AI Dermatology Screening" as a high-growth segment for the Canine Atopic Dermatitis Market, allowing general practitioners to access the expertise of a board-certified dermatologist...0 Commentaires 0 Parts 660 Vue 0 Aperçu
-
Exploring the Role of Advanced Environmental Diagnostics in the Canine Atopic Dermatitis Market for 2025In late 2025, the identification of specific allergic triggers has evolved from a "best guess" approach to a highly accurate molecular science. Gone are the days when a diagnosis of "atopy" was purely a catch-all term for an itchy dog. Within the Canine Atopic Dermatitis Market, the latest serological tests can now detect over two hundred different environmental allergens using only a few...0 Commentaires 0 Parts 844 Vue 0 Aperçu
-
The Revolutionary Impact of Monoclonal Antibody Therapy on the Management of Allergic Pruritus in Canines during 2025One of the most significant breakthroughs in the 2025 veterinary field is the widespread adoption of monoclonal antibody therapy for the treatment of canine atopic dermatitis. Specifically, the use of lokivetmab has transformed the life of millions of dogs by targeting and neutralizing interleukin-31, a key cytokine responsible for sending itch signals to the brain. Unlike traditional chemical...0 Commentaires 0 Parts 829 Vue 0 Aperçu
English
Arabic
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek